Background
In 2018, Elanco launched a life-changing osteoarthritis relief medication for dogs called Galliprant® (grapiprant tablets). Galliprant is a first-of-its-kind, targeted NSAID that treats canine osteoarthritis pain and inflammation. Safe to use daily, Galliprant delivers osteoarthritis pain relief in a convenient, flavored chewable tablet.
Challenge
Encourage trial and loyal use of Galliprant through a sweepstakes for both vet clinics and pet owners with FitBark as a prize.
Solution
This was a fun partnership with colleague Luke Meseke at Callahan in 2019. Luke dreamed up the exclamation point dotted with a branded tennis ball—a key part of the brand identity. I delivered print production direction with soft-touch box wraps, foil stamping and a diecut to create a memorable reveal for contest winners.
Awards // AAF Kansas City Gold ADDY
Art direction and design // Luke Meseke and Chris Ralston    
Production // Connie Nolte
Account direction // Brandi Frye


You may also like

Back to Top